第一工業製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4461/E00885 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/03/23 | 日証協 | 300,000株 | +4.17% | 64,000株 | -46.67% | 404,042株 | +13.48% | 67,928株 | -34.06% |
2018/03/16 | 日証協 | 288,000株 | +34.58% | 120,000株 | +255.03% | 356,043株 | +17.88% | 103,013株 | +51.49% |
2018/03/09 | 日証協 | 214,000株 | +4.9% | 33,800株 | +463.33% | 302,030株 | +22.26% | 68,000株 | +106.06% |
2018/03/02 | 日証協 | 204,000株 | -24.08% | 6,000株 | -93.68% | 247,030株 | -1.59% | 33,000株 | -57.14% |
2018/02/23 | 日証協 | 268,720株 | -17.53% | 94,930株 | -12.39% | 251,030株 | +4.15% | 77,000株 | +134.83% |
2018/02/16 | 日証協 | 325,850株 | +9.77% | 108,360株 | -5.34% | 241,030株 | -23.25% | 32,790株 | -71.92% |
2018/02/09 | 日証協 | 296,850株 | +2.14% | 114,478株 | +221.31% | 314,030株 | +9.41% | 116,778株 | +57.81% |
2018/02/02 | 日証協 | 290,628株 | -3.21% | 35,628株 | -40.51% | 287,030株 | +1.41% | 74,000株 | +23.33% |
2018/01/26 | 日証協 | 300,260株 | -6.42% | 59,888株 | -38.8% | 283,030株 | +5.99% | 60,000株 | +25% |
2018/01/19 | 日証協 | 320,855株 | +5.59% | 97,855株 | +227.77% | 267,030株 | +2.69% | 48,000株 | +700% |
2018/01/12 | 日証協 | 303,855株 | +3.4% | 29,855株 | +132.24% | 260,030株 | -34.67% | 6,000株 | -96.7% |
2018/01/05 | 日証協 | 293,855株 | -5.77% | 12,855株 | -46.11% | 398,042株 | +66.54% | 182,012株 | +391.61% |
2017/12/29 | 日証協 | 311,855株 | -34.4% | 23,855株 | -54% | 239,008株 | -4.81% | 37,024株 | -7.44% |
2017/12/22 | 日証協 | 475,395株 | -2.78% | 51,855株 | -70.37% | 251,097株 | -22.67% | 40,000株 | +300% |
2017/12/15 | 日証協 | 489,000株 | +41.33% | 175,000株 | +196.61% | 324,702株 | +2.2% | 10,000株 | -82.94% |
2017/12/08 | 日証協 | 346,000株 | -7.73% | 59,000株 | -10.61% | 317,716株 | -5.47% | 58,619株 | +432.37% |
2017/12/01 | 日証協 | 375,000株 | -7.73% | 66,000株 | +146.36% | 336,114株 | -15.78% | 11,011株 | -44.95% |
2017/11/24 | 日証協 | 406,395株 | -9.37% | 26,790株 | -52.5% | 399,103株 | -8.69% | 20,000株 | -82.14% |
2017/11/17 | 日証協 | 448,395株 | +3.22% | 56,395株 | -68.63% | 437,103株 | +8.98% | 112,000株 | +8.71% |
※株式分割は考慮していませんのでご注意ください。
Page Top